Dr Amy Borenstein is a neuroepidemiologist with over 35 years of experience specializing in identifying risk factors for Alzheimer’s disease and related dementias, as well as other neurologic diseases such as Parkinson’s disease. She has contributed significantly to the discovery of many risks and protective factors for these disorders. Her early work examined how culture and geography impact the risk of memory disorders of late life, and she worked on harmonizing the definition of cognitive impairment and the diagnosis of dementia across countries. Dr Borenstein has conducted and participated in dementia studies in diverse racial and ethnic populations. Her later work has focused on the evidence that Alzheimer’s disease is more than brain pathology and that brain reserve or functional brain tissue interacts with neuropathology to cause the clinical dementia syndrome. She is currently interested in early life determinants of Alzheimer’s and life-course approaches to the prevention of Alzheimer’s disease and related dementias. Dr Borenstein received her Bachelor's degree from Pitzer College in Claremont, CA, her Master's in Public Health from the University of Michigan, and her PhD in Public Health/Epidemiology from the University of Washington. She worked at Battelle Memorial Institute in Seattle, WA, after graduating with her PhD and later joined the faculty at the University of South Florida College of Public Health in Tampa, FL. Currently, she is a Founding Professor of Epidemiology at the new Herbert Wertheim School of Public Health and Human Longevity Science at the University of California – San Diego. In 2016, she co-wrote a comprehensive book, Alzheimer’s Disease: Life Course Perspectives on Risk Reduction (co-author, Dr James A. Mortimer).